In contrast, low levels of adiponectin are linked with increased prevalence of obesity-associated cardiovascular disorders and detrimental cardiovascular outcomes; therefore, strategies aimed at increasing the adiponectin/leptin ratio have been proposed as a therapeutic approach to cardiovascular dysfunction [16]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.